The Johns Hopkins Malaria Research Institute will host the 7th Future of Malaria Research Symposium on November 12, prior to the American Society of Tropical Medicine and Hygiene’s annual meeting. Students, postdoctoral researchers, and early career scientists are encouraged to submit an abstract to be considered for a short or long talk. Dr. Etienne Bilgo, Postdoctoral Fellow in Biomedical Sciences
This meeting hosted by the National Academies will focus on receiving information from the research community on low dose radiation research priorities and lessons to be learned from managing multidisciplinary programs. What are your views on research priorities for low dose radiation research? How can epidemiology contribute to further understanding risks? Molecular approaches to improve
The FDA will hold a virtual public meeting on November 16, 2021, on enhanced drug distribution security at the package level. The purpose of this public meeting is to provide members of the pharmaceutical distribution supply chain and other interested stakeholders an opportunity to provide input to FDA on the implementation of the enhanced drug
The American Society for Tropical Medicine and Hygiene (ASTMH) will gather virtually from 17-21 November for the Annual Meeting of leaders and scientific experts invested in tropical medicine and global health. The virtual gathering will feature a wide range of COVID-19 related work, including reports on the potential protective effects of malaria, new vaccine innovations
The COVID-19 pandemic has illuminated and exacerbated challenges in caring for people of all ages with serious illness. The response to many of these challenges involved rapid innovation and as such provides valuable lessons learned that will likely significantly alter the field of serious illness care in the post-pandemic era. The Roundtable on Quality Care
The FDA Antimicrobial Drugs Advisory Committee (AMDAC) will convene on 30 November 2021 to discuss Merck and Ridgeback’s request for emergency use (EUA) of molnupiravir oral capsules for treatment of mild to moderate COVID-19 in adults who are at risk for progressing to severe COVID-19 and/or hospitalization. an investigational antiviral drug to treat COVID-19. FDA
The COVID-19 pandemic has illuminated and exacerbated challenges in caring for people of all ages with serious illness. The response to many of these challenges involved rapid innovation and as such provides valuable lessons learned that will likely significantly alter the field of serious illness care in the post-pandemic era. The Roundtable on Quality Care
A virtual science conference on One Health: Integrating Human, Animal and Environmental Health will be held 3 December 2021. The One Health movement, which has come to prominence in the last decade, advocates greater cross-sectoral collaboration and communication across the human-animal-environment interface. There has been a long-standing recognition that population health is intrinsically linked to
The NTP Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM) is partnering with the Swiss Centre for Applied Human Toxicology and the Swiss State Secretariat for Economic Affairs to present a webinar series on “Current Concepts in Quantitative Risk Assessment for Skin Sensitization.” The next webinar in the series on December 8 will
